[NKTR] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 37.94%
YoY- 26.49%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 22,023 23,625 21,585 24,822 25,009 24,921 28,330 -15.41%
PBT -56,544 -59,204 -158,968 -90,267 -145,649 -129,594 -125,162 -41.03%
Tax 3,144 -155 100 126 -4 112 357 324.77%
NP -59,688 -59,049 -159,068 -90,393 -145,645 -129,706 -125,519 -38.99%
Tax Rate - - - - - - - -
Total Cost 81,711 82,674 180,653 115,215 170,654 154,627 153,849 -34.34%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -271.03 -249.94 -736.94 -364.16 -582.37 -520.47 -443.06 -27.87%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.32 -0.31 -0.85 -0.49 -0.79 -0.70 -0.69 -40.00%
EPS Diluted -0.32 -0.31 -0.85 -0.49 -0.79 -0.70 -0.69 -40.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.